open access

Vol 20, No 3 (2015)
Original research articles
Published online: 2015-05-01
Submitted: 2014-08-12
Get Citation

Effectiveness of PET/CT with F-fluorothymidine in the staging of patients with squamous cell head and neck carcinomas before radiotherapy

Radovan Vojtíšek, Jiří Ferda, Jindřich Fínek
DOI: 10.1016/j.rpor.2015.01.005
·
Rep Pract Oncol Radiother 2015;20(3):210-216.

open access

Vol 20, No 3 (2015)
Original research articles
Published online: 2015-05-01
Submitted: 2014-08-12

Abstract

Aim

The aim of our study was to compare the staging of the disease declared before anticancer treatment was begun with the staging that was found after the planning PET/CT scanning with 18F-FLT was performed.

Background

PET/CT in radiotherapy planning of head and neck cancers can facilitate the contouring of the primary tumour and the definition of metastatic lymph nodes.

Materials and methods

Between November 2010 and November 2013, 26 patients suffering from head and neck carcinomas underwent planning PET/CT examination with 18F-FLT. We compared the staging of the disease and the treatment strategy declared before and after 18F-FLT-PET/CT was performed.

Results

The findings from 18FLT-PET/CT led in 22 patients to a change of staging: in 19 patients it led to upstaging of the disease and in 3 patients it led to downstaging of the disease. In one patient, a secondary malignancy was found.

Conclusions

We have confirmed in this study that the use of 18F-FLT-PET/CT scanning in radiotherapy planning of squamous cell head and neck carcinomas has a great potential in the precise evaluation of disease staging and consequently in the precise determination of target volumes.

Abstract

Aim

The aim of our study was to compare the staging of the disease declared before anticancer treatment was begun with the staging that was found after the planning PET/CT scanning with 18F-FLT was performed.

Background

PET/CT in radiotherapy planning of head and neck cancers can facilitate the contouring of the primary tumour and the definition of metastatic lymph nodes.

Materials and methods

Between November 2010 and November 2013, 26 patients suffering from head and neck carcinomas underwent planning PET/CT examination with 18F-FLT. We compared the staging of the disease and the treatment strategy declared before and after 18F-FLT-PET/CT was performed.

Results

The findings from 18FLT-PET/CT led in 22 patients to a change of staging: in 19 patients it led to upstaging of the disease and in 3 patients it led to downstaging of the disease. In one patient, a secondary malignancy was found.

Conclusions

We have confirmed in this study that the use of 18F-FLT-PET/CT scanning in radiotherapy planning of squamous cell head and neck carcinomas has a great potential in the precise evaluation of disease staging and consequently in the precise determination of target volumes.

Get Citation

Keywords

[[ce:sup loc=" pre" ]]18F-fluorothymidine; PET/CT; Radiotherapy planning; Head and neck carcinomas

About this article
Title

Effectiveness of PET/CT with F-fluorothymidine in the staging of patients with squamous cell head and neck carcinomas before radiotherapy

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 20, No 3 (2015)

Pages

210-216

Published online

2015-05-01

DOI

10.1016/j.rpor.2015.01.005

Bibliographic record

Rep Pract Oncol Radiother 2015;20(3):210-216.

Keywords

[[ce:sup loc="pre"]]18F-fluorothymidine
PET/CT
Radiotherapy planning
Head and neck carcinomas

Authors

Radovan Vojtíšek
Jiří Ferda
Jindřich Fínek

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl